New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 2, 2014
08:13 EDTSTJSt. Jude Medical resolves FDA warning letter for Sylmar facility
St. Jude Medical announced that it has been notified by the U.S. Food and Drug Administration that issues cited in the Sylmar, California facility’s warning letter have been addressed. The company said, “We take our responsibility as a medical device manufacturer very seriously. We are encouraged by the resolution of the FDA’s warning letter and will continue to work to ensure the highest standards are met across our manufacturing facilities. St. Jude Medical is committed to providing our patients, customers and regulators with products and services that meet or exceed their expectations of safety, high-quality performance, reliability and service.”
News For STJ From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 14, 2015
09:03 EDTSTJSt. Jude Medical sees Q4 adjusted EPS within $1.02-$1.04 guidance range
Subscribe for More Information
09:02 EDTSTJSt. Jude Medical sees Q4 net sales approximately $1.439B, consensus $1.44B
Subscribe for More Information
09:01 EDTSTJSt. Jude Medical authorizes $500M share repurchase program
The company announced that its board of directors has authorized the repurchase of up to $500M of St. Jude Medical common stock. The repurchases will occur at such times and at such prices as the management of the company determines and may be effected through transactions in the open market, in privately negotiated transactions or otherwise. Any shares acquired in the $500M repurchase program will be available for general corporate purposes, including offsetting dilution associated with stock option and other equity-based employee benefit plans. The company had approximately 287 million shares of common stock outstanding as of Jan. 13, 2015.
January 12, 2015
07:17 EDTSTJJPMorgan to hold a conference
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use